MEDP

Medpace Holdings Inc.

Price

$630.35

return (12m)

26.42%

p/e

35.08

p/bv

39.74

DIVIDEND YIELD

0.00%

MEDP price

Medpace Holdings

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MEDP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

2.00%

3 months

33.13%

1 year

26.42%

2 years

72.37%

5 years

230.44%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals MEDP

Valuation

P/E

35.08

Sector -3.50

Industry -3.50

P/BV

39.74

Sector 2.01

Industry 2.01

P/Revenue (PSR)

6.20

Sector 2.01

Industry 2.01

EV/EBITDA

109.03

Sector -223.67

Industry -223.67

EV/EBIT

114.02

Sector -47.92

Industry -47.92

P/EBITDA

28.21

Sector -21.50

Industry -21.50

P/EBIT

29.56

Sector -28.21

Industry -28.21

P/Total Assets

8.38

Sector 1.19

Industry 1.19

P/Net Current Assets

-30.09

Sector -10.26

Industry -10.26

P/Working Capital

-44.77

Sector -167.98

Industry -167.98

EPS

17.45

Sector -1.79

Industry -1.79

BVPS

15.40

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

46.84%

Sector 41.30%

Industry 41.30%

EBITDA Margin

21.71%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

20.76%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

20.97%

Sector -35.21%

Industry -35.21%

Net Profit Margins

17.67%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.34

Sector 0.02

Industry 0.02

Profitability

ROE

113.29%

Sector -56.67%

Industry -56.67%

ROA

23.89%

Sector -59.91%

Industry -59.91%

ROIC

23.56%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

0.73

Sector 2.89

Industry 2.89

Net Debt / EBITDA

-3.27

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

-3.42

Sector -8.06

Industry -8.06

Net Debt / Equity

-1.16

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.21

Sector 0.46

Industry 0.46

Liabilities/Assets

0.79

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

19.49%

Sector -

Industry -

5Y Earnings CAGR

22.00%

Sector -

Industry -

Fundamentals MEDP

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Medpace Holdings ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$630.35

Fair Value

$77.76

Upside

-87.66%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
MEDP Medpace Holdings Inc.	$630.35	26.42%	0.00%	35.08	39.74	113.29%	17.67%
JNJ Johnson & Johnson	$268.23	55.69%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.78	23.76%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$266.19	23.47%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$39.42	-31.83%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$152.26	94.13%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$168.43	10.54%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.68	47.30%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$72.60	-49.28%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$407.77	46.81%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$807.61	36.11%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$113.57	45.96%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$896.04	28.97%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$524.14	36.81%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$227.00	53.67%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$976.24	32.50%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.01	29.10%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MEDP Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Medpace Holdings

Medpace Holdings Inc.

Average Investor10 user rating

4.0 (16 people)

United States

12 years

Founded: 2014

2016

Time since IPO - 10 years

3.500

Employees

Medpace Holdings Inc. (United States) is listed on the Nasdaq and has a market capitalization of $17.24 billion, with shareholders equity totaling $433.86 million.

The company employs approximately 3.500 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Medpace Holdings Inc. reported $2.78 billion in revenue, generating net income of $491.50 million.

Key financial metrics include a P/E ratio of 35.08, a price-to-book (P/B) ratio of 39.74, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MEDP.

Market cap

$17.24 billion

Net worth

$433.86 million

$433,861,000.00

Assets

$2.06 billion

$2,057,181,000.00

Total Shares Outstanding

28.17 million

28,174,000

Average Daily Trading Volume

$276.07 Thousand

$276,074.58

Sector

Health Care

Industry

Biotechnology

MEDP

MEDP revenue and profits

Financial Results MEDP

DRAG THE FRAME TO SEE MORE DATA

MEDP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$896.04 29,22% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$227.00 55,89% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$268.23 57,46% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$266.19 23,40% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$152.26 96,81% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$168.43 12,76% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.78 23,71% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$896.04 29,22% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$227.00 55,89% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$268.23 57,46% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$266.19 23,40% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$152.26 96,81% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$168.43 12,76% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.78 23,71% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Medpace Holdings (MEDP) today?

The current price of Medpace Holdings (MEDP) is $630.35. The stock began the year trading around $561.65 and is currently priced at $630.35. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Medpace Holdings (MEDP) pay dividends?

Medpace Holdings (MEDP) did not pay dividends over the past year.

Is Medpace Holdings (MEDP) a good investment?

Medpace Holdings (MEDP) is currently trading at $630.35 with a P/E ratio of 35.08. This represents a 3,132% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 26.42%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Medpace Holdings (MEDP) stock?

You can buy Medpace Holdings (MEDP) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol MEDP and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Medpace Holdings (MEDP) yield today?

Over the past month, Medpace Holdings (MEDP) has returned 2.00% — 26.42% over the past year, and 230.44% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Medpace Holdings (MEDP) today at the current price of $630.35 your total investment would be $63,035.26.

Based on historical performance, the investment would have grown to approximately:

$79,689.18 after 1 year
$208,293.71 after 5 years
$63,035.26 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

MEDP

Medpace Holdings Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment MEDP

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING MEDP WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Medpace Holdings

Medpace Holdings Inc.

United States

12 years

2016

3.500

PROFIT X PRICE MEDP

Financial Results MEDP

MEDP cash flow

Asset, Revenue and Profit Growth - MEDP

MEDP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions